The compound pharmacy window threatens safety and innovation Policy October 17, 2025 Conflicting interestsgettyThe new class of GLP-1 drugs exemplifies both the potential of pharmaceutical innovation and the dangers of future developments…
Reforming PBM practices will improve the pharmacy market Policy December 4, 2023 Optimization arrows.getty Patients, the ultimate arbiter of health care, continue to bear the cost of the perverse incentives that drive…
